Exagen (XGN) Cash from Operations (2018 - 2026)

Exagen (XGN) has 9 years of Cash from Operations data on file, last reported at 10417000.0 in Q1 2026.

• Quarterly Cash from Operations rose 2.38% year-over-year to 10417000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13371000.0 (up 10.32% YoY) and the FY2025 annual result came in at 13625000.0, down 2.61% from the prior year.
• Cash from Operations slipped to 10417000.0 in Q1 2026, from 3013000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 8349000.0 in Q4 2023 to a low of 11154000.0 in Q2 2022.
• A 5-year average of 4936882.35 and a median of 5734000.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2023 — Cash from Operations soared 245.61% — and 2025, when it tumbled 930.03%.
• Tracing XGN's Cash from Operations over 5 years: stood at 5734000.0 in 2022, then soared by 245.61% to 8349000.0 in 2023, then sank by 95.65% to 363000.0 in 2024, then plunged by 930.03% to 3013000.0 in 2025, then plunged by 245.74% to 10417000.0 in 2026.
• The last three Cash from Operations figures came in at 10417000.0 (Q1 2026), 3013000.0 (Q4 2025), and 2944000.0 (Q3 2025), per Business Quant data.